Chronic intracerebroventricular (icv) infusion of prolactin (PRL) into the cerebral ventricles and mimicking central hyperprolactinemia in lactation has recently been shown to reduce anxiety and neuronal as well as neuroendocrine responses to acute stressor exposure. Here, we studied the effects of icv PRL on the activity of the oxytocin (OXT) and arginine vasopressin (AVP) systems of virgin female, ovariectomized, estradiol-substituted Wistar rats. Ovine PRL was delivered via osmotic minipumps at 0.01, 0.1 or 1 μg/h for 5 days. Under basal conditions, both plasma OXT and AVP concentrations were increased after chronic PRL treatment (1 μg/h). At hypothalamic level, this was accompanied by an increased c-fos and OXT mRNA expression within the supraoptic nucleus, the main source of plasma OXT, whereas AVP mRNA levels remained unchanged. No effect of PRL on c-fos or on nonapeptide mRNA expression was found in the hypothalamic paraventricular nucleus. Moreover, chronic PRL abolished the rise in plasma OXT induced by acute exposure to 30 min restraint stress in vehicle-treated rats. However, restraint stress did not significantly alter OXT or AVP mRNA expression in the hypothalamus of either vehicle- or PRL-treated animals. From these results we conclude that brain hyperprolactinemia alters the synthetic activity of OXT neurons and the secretory performance of OXT and AVP neurons within the hypothalamus, resulting in elevated plasma concentrations of both hormones under basal conditions. These changes are comparable to adaptations seen in the female peripartum period.

Keywords:
Prolactin, Oxytocin, Vasopressin, Supraoptic nucleus, Paraventricular nucleus, c-fos, Restraint stress
1.
Lucas B, Ormandy C, Binart N, Bridges R, Kelly P: Null mutation of the prolactin receptor gene produces a defect in maternal behavior. Endocrinology 1998;139:4102–4107.
2.
Bridges RS, Numan M, Ronsheim PM, Mann PE, Lupini CE: Central prolactin infusions stimulate maternal behavior in steroid treated, nulliparous female rats. Proc Natl Acad Sci USA 1990;87:8003–8007.
3.
Torner L, Toschi N, Nava G, Clapp C, Neumann ID: Increased hypothalamic expression of prolactin in lactation: Involvement in behavioural and neuroendocrine stress responses. Eur J Neurosci 2002;15:1381–1389.
4.
Noel M, Woodside B: Effects of systemic and central prolactin injections on food intake, weight gain, and estrous cyclicity in female rats. Physiol Behav 1993;54:151–154.
5.
Li C, Kelly P, Buntin J: Inhibitory effects of anti-prolactin receptor antibodies on prolactin binding in brain and prolactin-induced feeding behavior in ring doves. Neuroendocrinology 1995;61:125–135.
6.
Drago F, Bohus B, Gispen W, Scapagnini U, De Wied D: Prolactin-enhanced grooming behavior: interaction with ACTH. Brain Res 1983;263:277–282.
7.
Torner L, Toschi N, Pohlinger A, Landgraf R, Neumann ID: Anxiolytic and anti-stress effects of brain prolactin: Improved efficacy of antisense targeting of the prolactin receptor by molecular modeling. J Neurosci 2001;21:3207–3214.
8.
Donner N, Bredewold R, Maloumby R, Neumann ID: Chronic intracerebral prolactin attenuates neuronal stress circuitries in virgin rats. Eur J Neurosci 2007;25:1804–1814.
9.
Slattery DA, Neumann ID: No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain. J Physiol 2008;586:377–385.
10.
Torner L, Maloumby R, Nava G, Aranda J, Clapp C, Neumann ID: In vivo release and gene upregulation of brain prolactin in response to physiological stimuli. Eur J Neurosci 2004;19:1601–1608.
11.
Kokay IC, Bull PM, Davis RL, Ludwig M, Grattan DR: Expression of the long form of the prolactin receptor in magnocellular oxytocin neurons is associated with specific prolactin regulation of oxytocin neurons. Am J Physiol 2006;290:R1216–R1225.
12.
Kokay I, Grattan D: Expression of mRNA for prolactin receptor (long form) in dopamine and pro-opiomelanocortin neurones in the arcuate nucleus of non-pregnant and lactating rats. J Neuroendocrinol 2005;17:827–835.
13.
Crumeyrolle-Arias M, Latouche J, Jammes H, Djiane J, Kelly P, Reymond H, Haour F: Prolactin receptor in the rat hypothalamus: autoradiographic localization and characterization. Neuroendocrinology 1993;57:457–466.
14.
Mustafa A, Nyberg F, Bogdanovic N, Islam A, Suliman I, Lindgren U, Roos P, Adem A: Prolactin binding sites in rat brain and liver: effects of long-term ovariectomy and ovarian steroids. Neurosci Lett 1995;200:179–182.
15.
Pi X-J, Grattan D: Differential expression of the two forms of prolactin receptor mRNA within microdissected hypothalamic nuclei of the rat. Mol Brain Res 1998;59:1–12.
16.
Sugiyama T, Minoura H, Kawabe N, Tanaka M, Nakashima K: Preferential expression of long form prolactin receptor mRNA in the rat brain during the estrous cycle, pregnancy and lactation: hormones involved in its gene expression. J Endocrinol 1994;141:325–333.
17.
Augustine R, Kokay I, Andrews Z, Ladyman S, Grattan D: Quantitation of prolactin receptor mRNA in the maternal rat brain during pregnancy and lactation. J Mol Endocrinol 2003;31:221–232.
18.
Walker CD, Trottier G, Rochford J, Lavallée D: Dissociation between behavioral and hormonal responses to the forced swim stress in lactating rats. J Neuroendocrinol 1995;7:615–622.
19.
Neumann ID, Landgraf R, Bauce L, Pittman QJ: Osmotic responsiveness and crosstalk involving oxytocin, but not vasopressin or amino acids, between the supraoptic nuclei in virgin and lactating rats. J Neurosci 1995;15:3408–3417.
20.
Cave B, Wakerley J, Luckman S, Tortonese D: Hypothalamic targets for prolactin: assessment of c-fos induction in tyrosine hydroxylase- and proopiomelanocortin-containing neurones in the rat arcuate nucleus following acute central prolactin administration. Neuroendocrinology 2001;74:386–395.
21.
Parker S, Armstrong W, Sladek C, Grosvenor C, Crowley W: Prolactin stimulates the release of oxytocin in lactating rats: evidence for a physiological role via an action at the neural lobe. Neuroendocrinology 1991;53:503–510.
22.
Ghosh R, Sladek C: Prolactin modulates oxytocin mRNA during lactation by its action on the hypothalamo-neurohypophyseal axis Brain Res 1995;672:24–28.
23.
Ghosh R, Sladek CD: Role of prolactin and gonadal steroids in regulation of oxytocin mRNA during lactation. Am J Physiol 1995;269:E76–E84.
24.
Popeski N, Amir S, Diorio J, Woodside B: Prolactin and oxytocin interaction in the paraventricular and supraoptic nuclei: effects on oxytocin mRNA and nitric oxide synthase. J Neuroendocrinol 2003;15:687–696.
25.
Sarkar D: Evidence for prolactin feedback actions on hypothalamic oxytocin, vasoactive intestinal peptide and dopamine secretion. Neuroendocrinology 1989;49:520–524.
26.
Mejia S, Torner L, Jeziorski M, Gonzalez C, Morales M, de la Escalera G, Clapp C: Prolactin and 16K prolactin stimulate release of vasopressin by a direct effect on hypothalamo-neurohypophyseal system. Endocrine 2003;20:155–162.
27.
Landgraf R, Neumann I, Holsboer F, Pittman Q: Interleukin-1β stimulates both central and peripheral release of vasopressin and oxytocin in the rat. Eur J Neurosci 1995;7:592–598.
28.
Paxinos G, Watson C: The Rat Brain in Stereotactic Coordinates. New York, Academic Press 1998.
29.
Erdtmann-Vourliotis M, Mayer P, Riechert U, Handel M, Kriebitzsch J, Hollt V: Rational design of oligonucleotide probes to avoid optimization steps in in situ hybridization. Brain Res Brain Res Protoc 1999;4:82–91.
30.
Lightman S, Young W: Lactation inhibits stress-mediated secretion of corticosterone and oxytocin and hypothalamic accumulation of corticotropin-releasing factor and enkephalin messenger ribonucleic acids. Endocrinology 1989;124:2358–2364.
31.
Neumann ID, Johnstone HA, Hatzinger M, Liebsch G, Shipston M, Russell JA, Landgraf R, Douglas AJ: Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes. J Physiol (Lond) 1998;508:289–300.
32.
Russell JA, Douglas AJ, Ingram CD: Brain preparations for maternity-adaptive changes in behavioral and neuroendocrine systems during pregnancy and lactation. An overview. Prog Brain Res 2001;133:1–38.
33.
Grattan D, Pi X-J, Andrews Z, Augustine R, Kokay I, Summerfield M, Todd B, Bunn S: Prolactin receptors in the brain during pregnancy and lactation: implications for behavior. Horm Behav 2001;40:115–124.
34.
Torner L, Neumann ID: The brain prolactin system: Involvement in stress response adaptations in lactation. Stress 2002;5:249–257.
35.
Windle R, Wood S, Shanks N, Perks P, Conde G, Da Costa A, Ingram C, Lightman S: Endocrine and behavioral responses to noise stress: comparison of virgin and lactating female rats during nondisrupted maternal activity. J Neuroendocrinol 1997;9:407–414.
36.
Ring R, Malberg J, Potestio L, Ping J, Boikess S, Luo B, Schechter L, Rizzo S, Rahman Z, Rosenzweig-Lipson S: Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology 2006;185:218–225.
37.
Neumann ID, Torner L, Wigger A: Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats. Neuroscience 2000;95:567–575.
38.
Bale T, Davis A, Auger A, Dorsa D, McCarthy M: CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J Neurosci 2001;21:2546–2552.
39.
Blume A, Bosch O, Miklos S, Torner L, Wales L, Waldherr M, Neumann ID: Oxytocin reduces anxiety via Erk1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur J Neurosci 2008;27:1947–1956.
40.
Windle R, Kershaw Y, Shanks N, Wood S, Lightman S, Ingram C: Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J Neurosci 2004;24:2974–2982.
41.
Blume A, Torner L, Liu Y, Subburaju S, Aguilera G, Neumann ID: Prolactin activates map kinase signaling and corticotropin releasing hormone transcription in rat hypothalamic neurons. Endocrinology 2009;150:1841–1849.
42.
Walker C, Toufexis D, Burlet A: Hypothalamic and limbic expression of CRF and vasopressin during lactation: implications for the control of ACTH secretion and stress hyporesponsiveness. Prog Brain Res 2001;133:99–110.
43.
Yue C, Mutsuga N, Scordalakes EM, Gainer H: Studies of oxytocin and vasopressin gene expression in the rat hypothalamus using exon- and intron-specific probes. Am J Physiol 2006;290:R1233–R1241.
44.
Landgraf R, Neumann I, Pittman Q: Septal and hippocampal release of vasopressin and oxytocin during late pregnancy and parturition in the rat. Neuroendocrinology 1991;54:378–383.
45.
Van Tol H, Bolwerk E, Liu B, Burbach J: Oxytocin and vasopressin gene expression in the hypothalamo-neurohypophyseal system of the rat during the estrous cycle, pregnancy, and lactation. Endocrinology 1988;122:945–951.
46.
Caldwell H, Lee H, Macbeth A, Young W: Vasopressin: behavioral roles of an ‘original’ neuropeptide. Prog Neurobiol 2008;84:1–24.
47.
Bosch OJ, Neumann ID: Brain vasopressin regulates maternal behavior independent of dams’ trait anxiety. Proc Natl Acad Sci USA 2008;105:17139–17144.
48.
Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA: Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998;19:225–268.
49.
Ma F, Anderson G, Gunn T, Goffin V, Grattan D, Bunn S: Prolactin specifically activates signal transducer and activator of transcription 5b in neuroendocrine dopaminergic neurons. Endocrinology 2005;146:5112–5119.
50.
Kishi K, Kobayashi F: Role of prolactin in controlling prolactin surges in pseudopregnant rats. Biol Reprod 1984;30:879–885.
51.
Neill J, Freeman M, Tillson S: Control of the proestrus surge of prolactin and luteinizing hormone secretion by estrogens in the rat. Endocrinology 1971;89:1448–1453.
52.
Pi X-J, Grattan D: Distribution of prolactin receptor immunoreactivity in the brain of estrogen-treated, ovariectomized rats. J Comp Neurol 1998;394:462–474.
53.
Shamgochian M, Avakian C, Truong N, Stone S, Tang K, DeVito W: Regulation of prolactin receptor expression by estradiol in the female rat brain. Neuroreport 1995;6:2537–2541.
54.
Anderson G, Kieser D, Steyn F, Grattan D: Hypothalamic prolactin receptor messenger ribonucleic acid levels, prolactin signaling, and hyperprolactinemic inhibition of pulsatile luteinizing hormone secretion are dependent on estradiol. Endocrinology 2008;149:1562–1570.
55.
Figueiredo HF, Dolgas CM, Herman JP: Stress activation of cortex and hippocampus is modulated by sex and stage of estrus. Endocrinology 2002;143:2534–2540.
56.
Windle R, Gamble L, Kershaw Y, Wood S, Lightman S, Ingram C: Gonadal steroid modulation of stress-induced hypothalamo-pituitary-adrenal activity and anxiety behavior: role of central oxytocin. Endocrinology 2006;147:2423–2431.
57.
Amico J, Thomas A, Hollingshead D: The duration of estradiol and progesterone exposure prior to progesterone withdrawal regulates oxytocin mRNA levels in the paraventricular nucleus of the rat. Endocr Res 1997;23:141–156.
58.
Crowley RS, Insel TR, O’Keefe JA, Kim NB, Amico JA: Increased accumulation of oxytocin messenger ribonucleic acid in the hypothalamus of the female rat: induction by long-term estradiol and progesterone administration and subsequent progesterone withdrawal. Endocrinology 1995;136:224–231.
59.
Da Costa A, Ma X, Ingram C, Lightman S, Aguilera G: Hypothalamic and amygdaloid corticotropin-releasing hormone (CRH) and CRH receptor-1 mRNA expression in the stress-hyporesponsive late pregnant and early lactating rat. Mol Brain Res 2001;91:119–130.
60.
Wotjak C, Naruo T, Muraoka S, Simchen R, Landgraf R, Engelmann M: Forced swimming stimulates the expression of vasopressin and oxytocin in magnocellular neurons of the rat hypothalamic paraventricular nucleus. Eur J Neurosci 2001;13:2273–2281.
61.
Vellucci S, Parrott R: Vasopressin and oxytocin gene expression in the porcine forebrain under basal conditions and following acute stress. Neuropeptides 1997;5:431–438.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.